Pepticom’s new article From finance to molecular modeling algorithms
The risk and return heuristic describes a novel new approach for Peptide discovery. ( https://www.researchtrends.net/tia/title_issue.aspid=26&in=0&vn=18&type=3″
Pepticom’s BDO, Dr. Maayan Elias Robicsek, will attend the BIO-EUROPE SPRING 2018 partnering conference.
The conference will take place on March 12-14 in Amsterdam, The Netherlands. For more information:maayan.elias@wordpress-544837-1818586.cloudwaysapps.com.
Pepticom has signed a third collaboration agreement with ADAMA Agricultural Solutions in the field of crop protection.
Pepticom initiates beta-testing for its cyclotide discovery algorithm.
If you have a protein target and want to find a cyclotide that binds it, please contact: amit.michaeli@wordpress-544837-1818586.cloudwaysapps.com.
Pepticom’s CEO attended and presented the company and its technology at the Shenzhen International Bio-Valley event.
Pepticom will attend the PEPTIDES conference in London, on July 6-7.
For more information: maayan.elias@wordpress-544837-1818586.cloudwaysapps.com.
Pepticom’s CTO, Amit Michaeli, will present at the Peptide Therapeutics Forum 2017 (Basel life 2017).
The talk: Artificial intelligence designed TLR4 peptide activators, will take place on September 12
Pepticom congratulates Prof. Amiram Goldblum, Pepticom’s co-Founder and Director
For winning the prestigious 2017 Kaye Innovation Award for dramatic improvements in drug discovery methods.
Pepticom will attend the 3rd INNOVATION China-Israel investment summit in China.
For more information and schedule: andre.miodezky@wordpress-544837-1818586.cloudwaysapps.com.
Pepticom’s CEO, Dr. Immanuel Lerner, will attend the 2017 BIO International Convention, June 19-22 in San Diego, California
For more information: maayan.elias@wordpress-544837-1818586.cloudwaysapps.com.